Literature DB >> 18805614

Effect of a vascular access nurse coordinator to reduce central venous catheter use in incident hemodialysis patients: a quality improvement report.

Kevan Roy Polkinghorne1, Mechelle Seneviratne, Peter G Kerr.   

Abstract

BACKGROUND: Starting hemodialysis therapy with an arteriovenous fistula (AVF) is associated with improved patient survival. Clinical audit showed that less than 50% of our patients started hemodialysis therapy with an AVF. STUDY
DESIGN: Quality improvement report, prospective before and after study. SETTING & PARTICIPANTS: Tertiary referral hospital with 184 patients starting hemodialysis therapy in 2005 and 2006. QUALITY IMPROVEMENT PLAN: Situational analysis showed poor overall coordination of surgical waiting lists. Multifaceted intervention included vascular access nurse coordinator and an algorithm to prioritize surgery. OUTCOMES: Vascular access used at first hemodialysis treatment in patients with pre-end-stage renal disease in the 12 months before and after the intervention. MEASUREMENTS: Proportions of patients starting hemodialysis therapy with an AVF.
RESULTS: Overall, 65% of patients started hemodialysis therapy with an AVF; 2%, with an arteriovenous graft; and 33%, with a catheter. The proportion of patients starting hemodialysis therapy with an AVF increased from 56% preimplementation to 75% postimplementation (P = 0.007). After adjustment for age, sex, late referral, cause of renal failure, and presentation type, patients starting dialysis therapy in the implementation phase were twice as likely to start treatment with an AVF (odds ratio, 2.85; P = 0.008). The total number of catheter-days in the implementation phase was half that of the preimplementation phase (2,833 v 4,685 days). LIMITATIONS: Nonrandomized study.
CONCLUSIONS: Implementation of a multifaceted intervention including a vascular access nurse and an algorithm to prioritize surgery significantly increased the proportion of patients starting dialysis therapy with an AVF by improving the overall coordination of the surgical waiting list.

Entities:  

Mesh:

Year:  2008        PMID: 18805614     DOI: 10.1053/j.ajkd.2008.06.026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  20 in total

1.  Fistula first: recent progress and ongoing challenges.

Authors:  Michael Allon
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

Review 2.  Clinical audit, a valuable tool to improve quality of care: General methodology and applications in nephrology.

Authors:  Pasquale Esposito; Antonio Dal Canton
Journal:  World J Nephrol       Date:  2014-11-06

3.  Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study.

Authors:  Kenneth J Woodside; Sarah Bell; Purna Mukhopadhyay; Kaitlyn J Repeck; Ian T Robinson; Ashley R Eckard; Sudipta Dasmunshi; Brett W Plattner; Jeffrey Pearson; Douglas E Schaubel; Ronald L Pisoni; Rajiv Saran
Journal:  Am J Kidney Dis       Date:  2018-02-09       Impact factor: 8.860

4.  Achieving the goal of the Fistula First breakthrough initiative for prevalent maintenance hemodialysis patients.

Authors:  Janet R Lynch; Haimanot Wasse; Nancy C Armistead; William M McClellan
Journal:  Am J Kidney Dis       Date:  2010-11-30       Impact factor: 8.860

5.  Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care.

Authors:  Timmy Lee
Journal:  Cardiovasc Eng Technol       Date:  2017-07-10       Impact factor: 2.495

6.  Arteriovenous graft placement in predialysis patients: a potential catheter-sparing strategy.

Authors:  Roman Shingarev; Ivan D Maya; Jill Barker-Finkel; Michael Allon
Journal:  Am J Kidney Dis       Date:  2011-04-02       Impact factor: 8.860

Review 7.  Quality indicators of vascular access procedures for hemodialysis.

Authors:  Branko Fila
Journal:  Int Urol Nephrol       Date:  2020-08-31       Impact factor: 2.370

8.  Management of mineral metabolism in hemodialysis patients: discrepancy between interventions and perceived causes of failure.

Authors:  Pasquale Esposito; Teresa Rampino; Marilena Gregorini; Carmine Tinelli; Annalisa De Silvestri; Fabio Malberti; Rosanna Coppo; Antonio Dal Canton
Journal:  J Nephrol       Date:  2014-05-08       Impact factor: 3.902

9.  Variation in fistula use across dialysis facilities: is it explained by case-mix?

Authors:  Navdeep Tangri; Ranjani Moorthi; Hocine Tighiouhart; Klemens B Meyer; Dana C Miskulin
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

10.  A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy.

Authors:  Hongyan Liu; Meng Gao; Hong Xu; Xin Guan; Li Lv; Sa Deng; Chenghong Zhang; Yan Tian
Journal:  Pharm Res       Date:  2015-09-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.